These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

470 related items for PubMed ID: 33276805

  • 1. Efficacy and safety of bempedoic acid alone or combining with other lipid-lowering therapies in hypercholesterolemic patients: a meta-analysis of randomized controlled trials.
    Zhao X, Ma X, Luo X, Shi Z, Deng Z, Jin Y, Xiao Z, Tan L, Liu P, Jiang S, Shu Y, Tang B, Qiu C.
    BMC Pharmacol Toxicol; 2020 Dec 04; 21(1):86. PubMed ID: 33276805
    [Abstract] [Full Text] [Related]

  • 2. Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy.
    Ballantyne CM, Laufs U, Ray KK, Leiter LA, Bays HE, Goldberg AC, Stroes ES, MacDougall D, Zhao X, Catapano AL.
    Eur J Prev Cardiol; 2020 Apr 04; 27(6):593-603. PubMed ID: 31357887
    [Abstract] [Full Text] [Related]

  • 3. Bempedoic Acid and Ezetimibe for the Treatment of Hypercholesterolemia: A Systematic Review and Meta-Analysis of Randomized Phase II/III trials.
    Bhagavathula AS, Al Matrooshi NO, Clark CCT, Rahmani J.
    Clin Drug Investig; 2021 Jan 04; 41(1):19-28. PubMed ID: 33368025
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study.
    Ballantyne CM, Banach M, Mancini GBJ, Lepor NE, Hanselman JC, Zhao X, Leiter LA.
    Atherosclerosis; 2018 Oct 04; 277():195-203. PubMed ID: 29910030
    [Abstract] [Full Text] [Related]

  • 5. Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia.
    Banach M, Duell PB, Gotto AM, Laufs U, Leiter LA, Mancini GBJ, Ray KK, Flaim J, Ye Z, Catapano AL.
    JAMA Cardiol; 2020 Oct 01; 5(10):1124-1135. PubMed ID: 32609313
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance.
    Laufs U, Banach M, Mancini GBJ, Gaudet D, Bloedon LT, Sterling LR, Kelly S, Stroes ESG.
    J Am Heart Assoc; 2019 Apr 02; 8(7):e011662. PubMed ID: 30922146
    [Abstract] [Full Text] [Related]

  • 7. Lipid lowering with bempedoic acid added to a proprotein convertase subtilisin/kexin type 9 inhibitor therapy: A randomized, controlled trial.
    Rubino J, MacDougall DE, Sterling LR, Kelly SE, McKenney JM, Lalwani ND.
    J Clin Lipidol; 2021 Apr 02; 15(4):593-601. PubMed ID: 34172394
    [Abstract] [Full Text] [Related]

  • 8. Evaluating pharmacokinetics of bempedoic acid in the treatment of hypercholesterolemia.
    Cicero AFG, Fogacci F, Cincione I.
    Expert Opin Drug Metab Toxicol; 2021 Sep 02; 17(9):1031-1038. PubMed ID: 34197267
    [Abstract] [Full Text] [Related]

  • 9. Combination of bempedoic acid, ezetimibe, and atorvastatin in patients with hypercholesterolemia: A randomized clinical trial.
    Rubino J, MacDougall DE, Sterling LR, Hanselman JC, Nicholls SJ.
    Atherosclerosis; 2021 Mar 02; 320():122-128. PubMed ID: 33514449
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of bempedoic acid for the treatment of hypercholesterolemia: A systematic review and meta-analysis.
    Cicero AFG, Fogacci F, Hernandez AV, Banach M, Lipid and Blood Pressure Meta-Analysis Collaboration (LBPMC) Group and the International Lipid Expert Panel (ILEP).
    PLoS Med; 2020 Jul 02; 17(7):e1003121. PubMed ID: 32673317
    [Abstract] [Full Text] [Related]

  • 11. Effect of Bempedoic Acid on atherogenic lipids and inflammation: A meta-analysis.
    Masson W, Lobo M, Lavalle-Cobo A, Molinero G.
    Clin Investig Arterioscler; 2021 Jul 02; 33(3):117-126. PubMed ID: 33328138
    [Abstract] [Full Text] [Related]

  • 12. Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol.
    Ray KK, Bays HE, Catapano AL, Lalwani ND, Bloedon LT, Sterling LR, Robinson PL, Ballantyne CM, CLEAR Harmony Trial.
    N Engl J Med; 2019 Mar 14; 380(11):1022-1032. PubMed ID: 30865796
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Di Minno A, Lupoli R, Calcaterra I, Poggio P, Forte F, Spadarella G, Ambrosino P, Iannuzzo G, Di Minno MND.
    J Am Heart Assoc; 2020 Aug 04; 9(15):e016262. PubMed ID: 32689862
    [Abstract] [Full Text] [Related]

  • 14. Bempedoic Acid in the Treatment of Patients with Dyslipidemias and Statin Intolerance.
    Susekov AV, Korol LA, Watts GF.
    Cardiovasc Drugs Ther; 2021 Aug 04; 35(4):841-852. PubMed ID: 33502687
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the efficacy and safety of bempedoic acid in women and men: Pooled analyses from phase 3 trials.
    Goldberg AC, Banach M, Catapano AL, Duell PB, Leiter LA, Hanselman JC, Lei L, Mancini GBJ.
    Atherosclerosis; 2023 Nov 04; 384():117192. PubMed ID: 37648637
    [Abstract] [Full Text] [Related]

  • 16. Bempedoic Acid: A New Drug for an Old Problem.
    Nguyen D, Du N, Sulaica EM, Wanat MA.
    Ann Pharmacother; 2021 Feb 04; 55(2):246-251. PubMed ID: 32674598
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials.
    Laufs U, Ballantyne CM, Banach M, Bays H, Catapano AL, Duell PB, Goldberg AC, Gotto AM, Leiter LA, Ray KK, Bloedon LT, MacDougall D, Zhang Y, Mancini GBJ.
    J Clin Lipidol; 2022 Feb 04; 16(3):286-297. PubMed ID: 35346603
    [Abstract] [Full Text] [Related]

  • 18. Complementary low-density lipoprotein-cholesterol lowering and pharmacokinetics of adding bempedoic acid (ETC-1002) to high-dose atorvastatin background therapy in hypercholesterolemic patients: A randomized placebo-controlled trial.
    Lalwani ND, Hanselman JC, MacDougall DE, Sterling LR, Cramer CT.
    J Clin Lipidol; 2019 Feb 04; 13(4):568-579. PubMed ID: 31202641
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of bempedoic acid in patients with hypercholesterolemia: A systematic review and meta-analysis of randomized controlled trials.
    Dai L, Zuo Y, You Q, Zeng H, Cao S.
    Eur J Prev Cardiol; 2021 Jul 23; 28(8):825-833. PubMed ID: 34298558
    [Abstract] [Full Text] [Related]

  • 20. Clinical development of bempedoic acid: phase 2 and phase 3 clinical trials.
    Lekuona I, Pintó X.
    Clin Investig Arterioscler; 2021 May 23; 33 Suppl 1():58-64. PubMed ID: 33966815
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.